Pharmaceuticals & Biotechnology

 Pharmaceuticals & Biotechnology


Pharmaceuticals & Biotechnologyhealth_image.jpg
Pharmaceuticals & Biotechnology



Health Services by RSM


Pharmaceuticals & Biotech Advisory, Assurance & Consulting

Manufacturers, wholesalers and distributors in the biopharm sector have never before been more critical to the world economy.

Pharmaceuticals & Biotech Consulting, Advisory & Assurance

With the COVID-19 pandemic now into its second year and showing no signs of becoming ‘just another pandemic’, a strong pharmaceuticals and biotech sector is a vitally important cog in the healthcare sector.

At RSM, our healthcare specialists bring to the fore not only 100 years of business history from RSM but also a strong team of advisers with knowledge across the disciplines needed to carry on business in today’s technological environment. RSM provide advisory, compliance and risk management services to a range of pharmaceutical and biotechnology companies and organisations, both Australian and foreign-owned.

In addition to the core services offered by our corporate divisions, specialists teams can also offer more focused services. Whatever your needs may be, contact RSM to see how we can provide assurance and advice. Follow our links below or call me direct to see how RSM can assist.


Peter Saccasan is a Pharmacy business expert

Peter Saccasan
National Director, Pharmacy

T: +61 2 8226 4500
[email protected]




RSM offers Safe Harbour strategies

Positioning you and your pharmacy for success

18 February 2022
Your time is valuable and can be easily directed to lots of different areas.

Patent Box Tax Concessions Explained

17 February 2022
The Federal Government has recently published a Bill which introduces the proposed Australian Patent Box Regime announced in the 2021 Federal Budget.

What the proposed Patent Box regime could do for Australian manufacturing businesses

7 December 2021
In the 2021 Federal Budget, the Australian Government announced plans to introduce our nation’s first Patent Box regime. The regime, which already exists in more than 20 other countries, aims to encourage patent development and its associated research and development (R&D) in Australia.

Medical Research Future Fund

10 November 2021
The Research Data Infrastructure Initiative (RDII) forms part of the Australian Government’s $20 billion Medical Research Future Fund (MRFF). $80 million over 8 years has been committed to the RDII and is targeting the creation or extension of national research data infrastructure.

Cyber Security - Board, Audit and Risk Committee Responsibility

28 September 2021
There aren't too many weeks that go by where there isn’t a new significant data breach reported.

Operational Technology (OT) security in healthcare

16 August 2021
Cyber security incidents are continuing to grow exponentially globally. Pharma companies have rushed to find vaccines and have stepped up efforts to manufacture these in large numbers to meet global demand. Unfortunately, cyber criminals have also realised this and are now ramping up attacks on healthcare.

Cyber Security – A practical approach

9 August 2021
As the threat landscape worsens and we see new attacks emerging daily, organisations are left asking the question “what needs to change” to stop this?

Manufacturing Collaboration Stream - The Modern Manufacturing Initiative (MMI)

27 July 2021
The Modern Manufacturing Initiative (MMI) is a $1.3 billion initiative targeted at all businesses growing Australia’s Manufacturing capacity, building scale, and supply chain resilience.

Why public entities and non-profits need to step up cyber security

19 July 2021
As the past few years have shown, no organisation is exempt from the dangerous and malicious actions of criminal cyber entities. 

R&D Tax Incentive: EOFY Summary

24 June 2021
We have seen a number of developments to the Research and Development Tax Incentive (R&DTI) during the 2021 income year. 

ASIC extends reporting deadlines for 30 June lodgements

3 May 2021
ASIC has made several recent media announcements aimed to simplify the financial reporting process for 30 June 2021 year-ends. 

Grant applications now open for Space and Medical Products

1 March 2021
The Modern Manufacturing Initiative (MMI) is a $1.3b funding program, part of the Federal Government’s Modern Manufacturing Strategy that aims to build a strong and resilient manufacturing sector in Australia.

Removal of Special Purpose Financial Statements - What you need to know

10 February 2021
Recent changes to Australian Accounting Standards will mean that many for-profit entities have to prepare General Purpose Financial Statements (“GPFS”) for the first time, and are no longer able to prepare Special Purpose Financial Statements (“SPFS”).  In this article, we explain who is affected, and what the impact will be on those enti